Bvf Inc Replimune Group, Inc. Transaction History

Bvf Inc

  • $3.15 Billion
  • Q3 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$17.48 - $29.09 $10.8 Million - $18 Million
620,407 Added 40.75%
2,143,036 $37.8 Million
Q4 2022

Feb 14, 2023
BUY
$17.09 - $27.91 $10.2 Million - $16.6 Million
596,100 Added 64.34%
1,522,629 $41.4 Million
Q3 2021

Nov 15, 2021
BUY
$28.98 - $39.54 $220,276 - $300,543
7,601 Added 0.83%
926,529 $27.5 Million
Q2 2021

Aug 16, 2021
BUY
$28.5 - $39.37 $13 Million - $18 Million
457,500 Added 99.15%
918,928 $35.3 Million
Q1 2021

May 17, 2021
BUY
$30.22 - $45.57 $13.9 Million - $21 Million
461,428 New
461,428 $14.1 Million
Q4 2020

Feb 12, 2021
SELL
$23.5 - $52.65 $39.8 Million - $89.1 Million
-1,691,834 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$18.85 - $27.0 $11.7 Million - $16.8 Million
-623,219 Reduced 26.92%
1,691,834 $38.9 Million
Q2 2020

Aug 14, 2020
BUY
$9.76 - $25.95 $3.32 Million - $8.82 Million
339,844 Added 17.21%
2,315,053 $57.5 Million
Q1 2020

May 15, 2020
SELL
$8.9 - $19.08 $2.97 Million - $6.37 Million
-333,900 Reduced 14.46%
1,975,209 $19.7 Million
Q4 2019

Feb 14, 2020
BUY
$11.61 - $17.21 $6.49 Million - $9.63 Million
559,400 Added 31.97%
2,309,109 $33.1 Million
Q3 2019

Nov 14, 2019
BUY
$10.01 - $16.87 $251,251 - $423,437
25,100 Added 1.46%
1,749,709 $24.3 Million
Q2 2019

Aug 14, 2019
BUY
$12.51 - $17.28 $1.47 Million - $2.04 Million
117,792 Added 7.33%
1,724,609 $25.3 Million
Q1 2019

May 15, 2019
BUY
$10.26 - $16.24 $7.26 Million - $11.5 Million
707,200 Added 78.61%
1,606,817 $24.5 Million
Q4 2018

Feb 14, 2019
SELL
$9.97 - $15.57 $121,982 - $190,498
-12,235 Reduced 1.34%
899,617 $9 Million
Q3 2018

Nov 14, 2018
BUY
$14.99 - $22.14 $13.7 Million - $20.2 Million
911,852 New
911,852 $14.7 Million

Others Institutions Holding REPL

# of Institutions
149
Shares Held
68M
Call Options Held
52.3K
Put Options Held
80.3K
View Full List

About Replimune Group, Inc.

REPL Quotes by TradingView
  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $631M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email